Simultaneous free and glycosylated pyridinium crosslink determination in urine: Validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 26, 2011, Pages 2764-2771

  Monticelli, Elena ^a   Aman, Caroline Stéphanie ^a   Costa, Maria Letizia ^b   Rota, Paola ^b   Bogdan, Daniela ^c   Allevi, Pietro ^b   Cighetti, Giuliana ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ministry of Education Research Youth and Sports   (Romania)

Author keywords

Deoxypyridinoline; Fluorescence detection; Glycosylated pyridinoline; HPLC; Human urine; Pyridinoline

Indexed keywords

DEOXYPYRIDINOLINE; FLUORESCENCE DETECTION; GLYCOSYLATED; HPLC; HUMAN URINE; PYRIDINOLINE;

BONE; COLLAGEN; ENZYME ACTIVITY; EXTRACTION; FLUORESCENCE; RATING;

BODY FLUIDS;

COLLAGEN; DEOXYPYRIDINOLINE; GALACTOSYL PYRIDINOLINE; GLUCOSYL GALATOSYL PYRIDINOLINE; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; BONE FRAGILITY; BONE TURNOVER; CALIBRATOR; CHILD; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STANDARD; URINALYSIS; VALIDATION STUDY;

ADULT; AMINO ACIDS; BONE RESORPTION; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FEMALE; GALACTOSIDES; GLYCOSYLATION; HUMANS; HYDROLYSIS; LEAST-SQUARES ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 80052380153     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.07.044     Document Type: Article

References (40)

1. Seibel M.J., Robins S.P., Bilezikian J.P. Trends Endocrinol. Metab. 1992, 3:263.
2. Cloos C., Wahl P., Haaslacher C., Traber L., Kistner M., Jurkuhn K., Schmidt-Gayk H. Clin. Endocrinol. (Oxf.) 1998, 48:317.
3. Swaminathan R. Clin. Chim. Acta 2001, 313:95.
4. Viguet-Carrin S., Garnero P., Delmas P.D. Osteoporos. Int. 2006, 17:319.
5. Ferrari S., Zolezzi C., Pratelli L., Fasano M.C., Bacci G. Calcif. Tissue Int. 2003, 73:1.
6. Rauch F., Georg M., Stabrey A., Neu C., Blum W.F., Remer T., Manz F., Schoenau E. Clin. Chem. 2002, 48:315.
7. James I.T., Walne A.J., Perrett D. Ann. Clin. Biochem. 1996, 33:397.
8. Garnero P., Rousseau J.-C., Delmas P.D. Arthritis Rheum. 2000, 43:953.
9. Garnero P., Delmas P.D. Curr. Opin. Rheumatol. 2003, 15:641.
10. Robins S.P. Biochem. J. 1983, 215:167.
11. Gineyts E., Garnero P., Delmas P.D. Rheumatology 2001, 40:315.
12. Roth M., Uebelhart D. Clin. Chim. Acta 2003, 327:81.
13. Garnero P. New biochemical markers of cartilage turnover in osteoarthritis: recent developments and remaining challenges. BoneKEy Osteovision 2007, 4:7. http://www.bonekey-ibms.org/cgi/content/full/ibmske.
14. Garnero P., Gineyts E., Christgau S., Finck B., Delmas P.D. Arthritis Rheum. 2002, 46:21.
15. Garnero P., Delmas P.D. Curr. Opin. Rheumatol. 2004, 16:428.
16. Young-Min S., Cawston T., Marshall N., Coady D., Christgau S., Saxne T., Robins S., Griffiths I. Arthritis Rheum. 2007, 56:3236.
17. Takahashi M., Suzuki M., Naitou K., Miyamoto S., Kushida K. Rheumatology 1999, 38:133.
18. Vesper H.W., Audain C., Woolfitt A., Ospina M., Barr J., Robins S.P., Myers G.L. Anal. Biochem. 2003, 318:204.
19. Muller A., Jakob K., Hein G.E. Ann. Rheum. Dis. 2003, 62:65.
20. Srivastava A.K., Libanati C., Oberrauch W., Leenings J., Greenwald M., Baylink D.J. J. Bone Miner. Metab. 2003, 21:134.
21. Kraenzlin M.E., Kraenzlin C.A., Meier C., Giunta C., Steinmann B. Clin. Chem. 2008, 54:1546.
22. Vesper H.W., Smith S.J., Audain C., Myers G.L. Clin. Chem. 2001, 47:2029.
23. Vesper H.W., Demers L.M., Eastell R., Garnero P., Kleerekoper M., Robins S.P., Srivastava A.K., Warnick G.R., Watts N.B., Myers G.L. Clin. Chem. 2002, 48:220.
24. Kindt E., Rossi D.T., Gueneva-Boucheva K., Hallak H. Anal. Biochem. 2000, 283:71.
25. Sroga G.E., Vashishth D. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2011, 879:379.
26. Allevi P., Femia E.A., Rota P., Costa M.L., Anastasia M. Tetrahedron Asymmetry 2008, 19:2470.
27. Allevi P., Longo A., Anastasia M. Chem. Commun. (Camb.) 1999, 559.
28. Allevi P., Anastasia M. Tetrahedron Asymmetry 2003, 14:2005.
29. Allevi P., Cribiu R., Giannini E., Anastasia M. Bioconjugate Chem. 2005, 16:1045.
30. Allevi P., Colombo R., Giannini E., Anastasia M. Tetrahedron Asymmetry 2007, 18:1750.
31. Spacek P., Hulejova H., Adam M. J. Chromatogr. B: Biomed. Sci. Appl. 1997, 689:404.
32. US Department of Health and Human Services, US Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) Guidance for Industry: Bioanalytical Method Validation 2001.
33. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP) Guideline on Validation of Bioanalytical Methods. Doc. Ref: EMEA/CHMP/EWP/192217/2009 2009.
34. van de Merbel N.C. Trends Anal. Chem. 2008, 27:924.
35. Bicking M.K.L. LC-GC North Am. 2006, 24:402.
36. Eyre D.R., Weis M.A., Wu J.-J. J. Biol. Chem. 2010, 285:16675.
37. Yang L., Grey V. Clin. Biochem. 2006, 39:561.
38. Fricke O., Land C., Beccard R., Semler O., Stabrey A., Schoenau E. J. Bone Miner. Metab. 2009, 27:689.
39. Schegg B., Hulsmeier A.J., Rutschmann C., Maag C., Hennet T. Mol. Cell. Biol. 2009, 29:943.
40. Saito M., Marumo K. Osteoporos. Int. 2010, 21:195.